As such, the pharmacokinetics of SCBs should be investigated to far more fully recognize the implications of exposure to both equally the guardian SCBs as well as their active metabolites. Direct and oblique pharmacological exercise by SCBs on non-CB1/CB2 neurotransmitter and neurochemical signaling, like while in the serotonergic, dopaminergic, gl